GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 456.20
Bid: 454.80
Ask: 455.00
Change: -2.80 (-0.61%)
Spread: 0.20 (0.044%)
Open: 460.00
High: 460.00
Low: 451.80
Prev. Close: 459.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Quarter Trading Update

22 Jul 2015 07:00

RNS Number : 7015T
QinetiQ Group plc
22 July 2015
 

 

 

News release

22 July 2015

 

 

QinetiQ Group plc

 

First Quarter Trading Update

 

 

QinetiQ Group plc, the defence, security and aerospace company, today issues a trading update covering the period from 31 March 2015 to date, prior to holding its Annual General Meeting at the Pennyhill Park Hotel, London Road, Bagshot, Surrey, GU19 5EU at 11am today.

Trading during the first quarter was in line with expectations and the Group reaffirms its previous guidance for performance in the full year to 31 March 2016.

In the UK, the Government's Strategic Defence and Security Review (SDSR) is now underway. The context for the SDSR was set by the "Summer budget" announced earlier this month in which the UK Government pledged to spend a minimum of 2% of GDP on defence in line with its NATO commitment. The specific allocation of the UK defence budget - including expenditure on test and evaluation, and science and technology - is unlikely to be determined until the SDSR is completed at the end of this calendar year. QinetiQ is well positioned to help customers meet the dual challenges of budget pressures and increasing global security threats.

The Group's EMEA Services division delivered a solid performance during the first quarter. The division has seen some customer contract award decisions deferred due to the market factors outlined above, or delayed by the requirement for additional approvals, particularly on larger contracts. However, revenue under contract is as expected at this stage in the financial year.

The Group's Global Products division has shorter order cycles and a more lumpy revenue profile than EMEA Services. As anticipated, it traded at similar levels to the prior year during the first quarter. A new leadership team is now in place in the US and is repositioning the business in response to continued challenging market conditions.

An additional £22m of the £150m share buyback programme was completed during the first quarter. At 17 July 2015, the Group had executed £130m of the buyback and expects to complete the programme in the next few months.

In balancing the continued market uncertainties with the strength of the Group's operations, the outlook for the full year to 31 March 2016 is unchanged from the preliminary results on 21 May 2015 as set out below:

Defence transformation, and the forthcoming Comprehensive Spending Review and SDSR are expected to have an impact on the UK defence market this year. This will provide future opportunities for EMEA Services to build on its strong record of delivering 'more for less', whilst recognising that in FY16 there will be uncertainty and the potential for interruptions to order flow. The portion of revenue under contract at the start of FY16 was similar to a year ago and the balance is supported by a pipeline of opportunities but order flow and contract cover will be watched closely over the coming months. Overall, given the opening backlog position, expectations for the performance of EMEA Services in the current financial year are unchanged.

In Global Products, newer products are recording notable milestones and the amount of revenue under contract at the start of FY16 is up slightly on a year ago, but the drawdown of American overseas military forces is continuing to depress demand for conflict-related products. As the division has a lumpy revenue profile which is dependent on the timing and shipment of key orders, there is a range of possible outcomes for the performance of Global Products in the current year.

Notes to Editors:

A FTSE250 company, QinetiQ uses its world class knowledge, research and innovation to provide high-end technical expertise and advice, to customers in the global aerospace, defence and security markets. QinetiQ's unique position enables it to be a trusted partner to government organisations, predominantly in the UK and the US, including defence departments as well as other international customers in targeted sectors.

 

For more information see www.QinetiQ.com 

 

Follow us on twitter @QinetiQ

 

Visit our blog at www.QinetiQ-blogs.com/QinetiQ

 

Download the QinetiQ investor relations app for iPad from the App Store.

 

For further information please contact:

 

Investor relations: David Bishop, QinetiQ +44 (0) 7920 108675

Media relations: QinetiQ press office +44 (0) 1252 393500

Rebecca Mitchell, Maitland +44 (0) 207 379 5151

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDFLFLEDFXBBZ
Date   Source Headline
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20241:54 pmRNSDirector Declaration
5th Mar 202412:08 pmRNSDirector Declaration
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20249:32 amRNSHolding(s) in Company
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 202411:55 amRNSResult of Meeting
5th Feb 20243:48 pmRNSDirector/PDMR Shareholding
19th Jan 20249:31 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSQ3 Trading Update and Share Buyback Programme
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.